SCHEMBL26433339

SCHEMBL26433339

c1ccc(-c2ccc3c(n2)c2nc(-c4ccccc4)cc4c5cc6c7cc(-c8ccccc8)nc8c9nc(-c%10ccccc%10)ccc9n(c6cc5n3c42)c78)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
TSHR P16473 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RAB9A P51151 1/20 0.34
ADORA2A P29274 3/20 0.34
ADORA1 P30542 3/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26433349 0.87 NPC1 (0.33) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL26433351 0.87 CYP19A1 (0.42) MAPTALDH1A1NPC1LMNAKDM4E
SCHEMBL26433343 0.84 NPC1 (0.34) MAPTALDH1A1NPC1LMNANPSR1
SCHEMBL26433379 0.83 MEN1 (0.39) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL26433387 0.81 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL26433247 0.81 IDO1 (0.38) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL26433346 0.80 KDM4E (0.40) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL26433377 0.77 NPC1 (0.35) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL26433378 0.77 CYP19A1 (0.35) MEN1KMT2AMAPTALDH1A1TSHR
SCHEMBL26433255 0.75 IDO1 (0.35) MEN1KMT2AMAPTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126543-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed
US-20230126543-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230126543-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE CYP1A1, AOX1, CRY1 MEN1 446/4885KMT2A 1754/4885MAPT 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.